Trial
NCT01887522
Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators
Innovative Therapies For Children with Cancer Consortium
Condition
Refractory Low-grade Gliomas
Intervention
Vinblastine + Nilotinib
Why stopped
the results of the interim analysis are clear with a significant advantage in terms of PFS in favor of the control arm (Vinblastine alone) over the investigational arm (Vinblastine + Nilotinib).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-31